Aytu BioPharma, Inc. - SIC # 2840 -

Ticker Exchange SIC # Website Latest Ticker
AYTU Nasdaq 2840 aytubio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aytu BioPharma, Inc.

Aytu BioPharma Appoints Dr. Gerwin Westfield as Senior Vice President of Scientific Affairs to Support Commercialization of EXXUA(TM) - Jun 25th, 2025 6:00 am
CEO & Director of Aytu BioPharma Joshua Disbrow Buys 77% More Shares - Jun 14th, 2025 6:21 am
Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan - Jun 9th, 2025 2:30 pm
Aytu BioPharma to commercialise Exxua for MDD in the US - Jun 9th, 2025 5:30 am
Aytu BioPharma Announces At the Market Pricing of $14.4 Million Upsized Public Offering of Common Stock - Jun 6th, 2025 6:01 am
Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United States - Jun 6th, 2025 6:00 am
Aytu BioPharma Third Quarter 2025 Earnings: Beats Expectations - May 16th, 2025 4:51 am
Aytu BioPharma Inc (AYTU) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - May 15th, 2025 1:17 am
Aytu BioPharma Reports Fiscal 2025 Third Quarter Operational and Financial Results - May 14th, 2025 2:05 pm
Aytu BioPharma to Report Fiscal 2025 Third Quarter Operational and Financial Results on May 14, 2025 - May 7th, 2025 2:15 pm
Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025 - Apr 21st, 2025 2:05 pm
Loss-Making Aytu BioPharma, Inc. (NASDAQ:AYTU) Set To Breakeven - Feb 15th, 2025 7:36 am
Aytu BioPharma Inc (AYTU) Q2 2025 Earnings Call Highlights: Strong Cash Position and Strategic ... - Feb 13th, 2025 6:00 am
Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results - Feb 12th, 2025 2:03 pm
Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025 - Feb 5th, 2025 3:50 pm
Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 - Jan 6th, 2025 7:00 am
Aytu BioPharma Proposes Settlement in Shareholder Lawsuit - Dec 5th, 2024 4:32 am
Aytu BioPharma Disclosure Notification - Dec 3rd, 2024 9:45 pm
Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM) - Nov 22nd, 2024 7:00 am
Aytu BioPharma First Quarter 2025 Earnings: Beats Expectations - Nov 16th, 2024 6:31 am